ARCHIVES

Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision

November 5, 1999

Breast Cancer Activist, Radiologist Are Added To Special Commission

November 6, 1992

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

March 31, 1989

Sprycell Approved for CML

November 5, 2010